Market: NYQ |
Currency:
Address:
📈 SMA Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$36.10
-
Upside/Downside from Analyst Target:
13.10%
-
Broker Call:
13
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
50-100%
-
Revenue Growth Range (1Y):
10-25%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for SMA
No earnings history available for this symbol.
📰 Related News & Research
-
SmartKem, Inc. Announces Series A Convertible Preferred Stock Offering and Entry into Material Definitive Agreements – March 2026
March 31, 2026
SmartKem, Inc. - Material Definitive Agreement and Nasdaq Co...
-
SmartBank Appoints Cynthia A. Cain as Chief Operating Officer to Lead Operations, Technology, and Innovation
March 31, 2026
SmartBank Announces Appointment of Chief Operating Officer ...
-
Latch, Inc. (DOOR): Integrated Smart Building Solutions for Multifamily Properties and the HelloTech Merger 33
March 31, 2026
Latch, Inc. (DOOR) 2025 10-K Key Investor Takeaways ...
-
1847 Holdings LLC: Small Business Acquisition Strategy, Management Services, and Competitive Strengths Explained
March 31, 2026
1847 Holdings LLC 2025 Annual Report: Investor-Focused Highl...
-
Tempest Therapeutics 2026 10-K: Pipeline Overview, CAR-T & Small Molecule Oncology Strategies, Key Partnerships, and Competitive Position
March 30, 2026
Tempest Therapeutics, Inc. 2025 Annual Report: Detailed Inve...
-
Newsmax Inc. Annual Report: Business Overview, Competitive Strengths, Risks, and Growth Strategies
March 27, 2026
Newsmax Inc. 2025 Annual Report: Key Investor Insights and S...
-
VenHub Global, Inc. – Autonomous Smart Stores Powered by AI Robotics, Patents, and Next-Gen Retail Technology
March 25, 2026
VenHub Global, Inc. Annual Report: Key Highlights for Invest...
-
Biomea Fusion, Inc. 2025 Annual Report: Advancing Oral Diabetes & Obesity Therapies with Innovative Small Molecule Drugs
March 25, 2026
Biomea Fusion 2025 10-K: Investor Highlights and Analysis ...
-
Newsmax Inc. Files Form 8-K with SEC: Company Details, Address, and NYSE Listing Information
March 24, 2026
Newsmax Inc. 8-K Report Analysis - March 2026 Newsmax In...
-
SolarEdge Technologies 2025 10-K/A: Smart Energy Solutions, Business Overview, and Forward-Looking Risk Factors
March 24, 2026
SolarEdge Technologies, Inc. 2025 Annual Report - Key Highli...
🔍 View more Reports